Abstract: Background: Pelargonium graveolens is an important medicinal plant traditionally used to heal wounds, ulcers, skin disorders and diarrhea. Despite its well-known antioxidant activity, the cytotoxicity of P. graveolens crude extract has not been well documented. Methodology: Methanolic fraction was extracted from P. graveolens leaves and was analyzed by GC/MS. Two modes of experiments were performed: First, assessing antioxidant activity using DPPH free radicals, while the second, detecting the effect of the extract on MCF-7 cell morphology, viability, stress responses, mitochondrial potential and Reactive Oxygen Species (ROS) generation were examined with MTT and High Content Screening (HCS) scanning. Results: Twenty four compounds have been identified which constitute 90.02% of the extract. A dose-dependent reduction in DPPH was recorded with IC50 of 484 μg mL1. The MTT results showed a dose-dependent anti-tumor activity and reduction in cell viability against MCF-7 cells with IC50 of 288 μg mL1. Further examination of HCS results indicated a dose-dependently growth inhibition of MCF-7 cells (53.92% at 200 μg mL1). Membrane permeability also increased in a dose-dependent manner, while only high concentrations caused alterations in nucleus morphology. A 40.3% reduction in the mitochondrial potential was observed. Such disruptions resulted in the release of cytochrome C, for which a 0.7 fold increase was detected in the treated MCF-7 cells compared with untreated cells. Treatment also resulted in a 0.53 and 1.32 folds increases in generation of ROS at 100 and 200 μg mL1, respectively. Conclusion: Methanolic extract of P. graveolens exhibited a significant antioxidant activity and has profound cytotoxic activity against MCF-7 cell line.
INTRODUCTION
For centuries plants were considered to be one of the most abundant sources of medicines and drugs. The vast diversity of plant species all around the world as well as their constituents and active compounds, made their applications range from simple traditional rituals into disease specific treatments, after extensive research on chemical composition, mode of action and toxicity.
One of these plants is Pelargonium graveolens. It is an aromatic plant, belonging to the Geraniaceae family that grows in temperate areas of the world1. Essential oils are the major components of P. graveolens. The oils mainly consist of β-citronellol, geraniol, δ-selinene and l-menthone2. In addition to its benefits in the food and beverage industries3, current research has focused on the importance of P. graveolens essential oils and their wide array of biological activities. Examples of this include: Antimicrobial and antimalarial activity4 and antiasthmatic, antiallergic, antidiarrhoeic and antihepatotoxic activities5. Extracts of P. graveolens have been shown to possess antioxidant properties and the ability to scavenge free radicals and reduce reactive oxygen species6,7. In addition, some reports suggest that extracts of P. graveolens exhibit a cytotoxic and antitumor activity8,9. Haag et al.10 proposed monoterpenes as the principle component of geranium essential oils, which have been shown to prevent mammary, lung, skin, liver and stomach cancers in rat models. However, few studies revealed the exact cytotoxic effects of P. graveolens extract on tumor cells and the cell morphological changes that occur after exposure to the extract.
Identifying the toxicity of new drugs is an important step before beginning marketing and general consumption of new drugs. Many procedures are currently used to detect the level of cytotoxicity of new compounds or drugs. Multi-parametric analysis is one of the most common approaches and uses flow cytometry and cellular imagingbased techniques, including high-content screening (HCS) to detect the level of compound toxicity and classification of the compound based on observed patterns of reversible and irreversible cellular injury11,12. It provides an easy and rapid method for identifying substances with apoptosis inducing characteristics using high throughput analysis. The standard measurements that multi-parametric analysis provides are (a) Nuclear morphology and intensity, (b) Mitochondrial trans-membrane potential, (c) Plasma membrane permeability, (d) Cell proliferation and (e) Cytochrome C release13. Accordingly this study aims to evaluate the antitumor and antioxidant properties of P. graveolens crude extracts in vitro using the human breast adenocarcinoma MCF-7 cell line via detection of the potential antioxidant activities through the DPPH-scavenging assay and investigate the anti-tumor properties by employing MTT assays and HCS for detecting the following cellular parameters: Cell viability, total nuclear intensity, membrane permeability, mitochondrial membrane potential changes, cytochrome C release and ROS generation.
MATERIALS AND METHODS
Materials: All chemicals were thankfully provided from Al-Nahrain University, Department of Biotechnology. The MTT kit was purchased from Intron Biotech (Korea), while Cellomics® Multiparameter Cytotoxicity 3 kit and ROS Cellomics kit were purchased from ThermoScientific (USA).
Plant materials: Leaves of P. graveolens were collected from local plant nurseries in Baghdad, Iraq. The collected leaves were washed thoroughly under tap water to remove trace chemicals and dust. After thorough washing, the P. graveolens leaves were dried by incubation overnight at 37°C. After incubation the fully dried leaves were blended in order to obtain a fine powder, which was used for extraction purpose.
Methanolic extraction: Dried powder (100 g) of P. graveolens leaves was treated with 500 mL methanol. The mixture was homogenized with a magnetic stirrer for 4 h at room temperature and then filtrated using Whatman filter paper No. 1. The filtrate solvent was cooled and centrifuged with 1500 rpm at 15°C for 30 min. The crude fraction was evaporated at 45°C using a rotary evaporator (IKA, Germany) under vacuum to obtain the final dried P. graveolens crude extract. The resulting pellet was subjected to further extraction by repeating the same procedure. The methanol fraction yielded 1.4 g.
GC/MS analysis: The P. graveolens extract was analyzed by GC-2010 Plus (Shimadzu, Japan) equipped with DB-5MS column (30 m long 0.25 mm i.d. and 0.25 μm thick, Agilent Technologies, J and W Scientific Products, USA). The injector and detector temperature were set at 250 and 230°C, respectively. The oven temperature started at 100°C and raised at a rate of 5°C min1 then held at 260°C for 1 min. Aliquot of 1 μL of sample was injected and helium was used as the carrier gas. The mass range was scanned from 50-550 amu. Identification for possible compounds and essential oils was carried out in Ministry of Science and Technology, Department of Water and Environmental Research (using NIST Library).
Evaluation of antioxidant activity using DPPH: Antioxidant activity was detected by using the DPPH radical scavenging assay according to the previously described procedure14. Aliquots (0.5 mL) of 2 folds serial dilutions of the extract and ascorbic acid (75, 125, 250, 500 and 1000 μg mL1) were added in reaction test tubes. Simultaneously, 3 mL of methanol-DMSO (9:1 v/v) and 0.3 mL of DPPH solution (0.1 mg mL1) were added to each concentration. Samples were shaken for a few seconds and allowed to stand in the dark at room temperature for 60 min. After 60 min the absorbance detected against bank at 517 nm. The percent inhibition of radical formation in the samples was calculated according to the following formula:
Tests were carried out in triplicate and the IC50 values of the samples were calculated using a log dose inhibition curve.
Cell line culture: Human breast adenocarcinoma MCF-7 cells15 were obtained from American Type Culture Collection (ATCC) and cultured in DMEM medium supplemented with 10% fetal bovine serum, 1% sodium bicarbonate, 103 IU penicillin G and 100 μg mL1 streptomycin. The MCF-7 cells were maintained in a CO2 incubator (5%) at 37°C.
MTT cytotoxicity assay: Protocol was performed following the manufacturer instructions. Cells (1×104 to 1×106 cells mL1) were grown in a 96 flat-well plate with a final volume of 200 mL well1. The plate was covered by sterilized parafilm, agitated gently and incubated at 37°C, 5% CO2 for 24 h. After incubation, the medium was removed and 200 mL of the 2 folds serial dilutions of P. graveolens crude extract (25, 50, 100, 200, 400 mg mL1) were added to the wells. Triplicates were performed at each concentration as well as controls. Plates were incubated at 37°C, 5% CO2 for 24 h. After exposure to extract, 10 mL of the MTT solution was added to each well. Plates were further incubated at 37°C, 5% CO2 for 4 h. The medium was then carefully removed and 100 mL of solubilization solution was added per well and incubated for 5 min. The absorbance was determined with an ELISA reader (Bio-rad, Germany) at a wavelength of 575 nm. The optical density readings were subjected to statistical analysis in order to calculate16 the IC50.
Multi-parameter cytotoxic assay: The multi-parameter cytotoxicity assay was performed to measure the five orthogonal MCF-7 cell health parameters after exposure to P. graveolens crude extract in vitro. The parameters were: Viability cell count, total nuclear intensity, cell membrane permeability, mitochondrial membrane permeability and cytochrome c release. Briefly, after 24 h of exposure with different concentrations of P. graveolens crude extract, the treated MCF-7 cells were stained with cell staining solution (MMP dye+permeability dye) for 30 min at 37°C. Cells were fixed, permeabilized and blocked before probing with primary cytochrome C antibody and secondary DyLight 649 conjugated goat anti-mouseIgG for 60 min each. Plates were analyzed using the ArrayScan HCS analyzer (ThermoScientific, USA).
ROS detection: MCF-7 cells (1×104) were seeded in 96-well plates for 24 h prior to exposure with different concentrations of P. graveolens crude extract. At the indicated time, 50 μL of staining solution (DMEM), containing 500 nM Hoechst 33342 and 2.5 μg mL1 dihydroethidium (DHE) were added to each well. Plates were incubated at 37°C for 30 min. The cells were fixed with PBS containing 3.5% formaldehyde for 15 min at room temperature. Finally, cells were washed with PBS and plate was evaluated using an ArraySacn HCS analyzer (ThermoScientific, USA).
Statistical analysis: A one-way analysis of variance (ANOVA) was performed to assess whether group variance was significant. Data were expressed as Mean±Standard Deviation (SD) and statistical significances were carried out using a GraphPad Prism version 6.
RESULTS
GC/MS analysis: The GC/MS analysis of P. graveolens methanol extract was listed in Table 1 and it was found that the extract contained 24 identified constituents which represent 90.02%.
The major component was citronellol 22.61% followed by palmitic acid 10.59, decanediol 10.39%, geraniol 9.04%, l-menthone 5.29%, pyroglutamic acid 4.83, linalool 4.82%, stearic acid 2.96%, germacrene-d 2.67%, agarospirol 2.43%, geranyl tiglate 2.38%, linalool oxide 2.23%, germacrene D 1.68% and γ-cadinene 1.38%. In addition 10 components were present in amount less than 1%. On the other hand, 9.98% out of the total was considered as non-identified constituent.
Antioxidant activity of Pelargonium graveolens crude extract: The scavenging activity of P. graveolens methanol extract was evaluated using stable DPPH free radical scavenging assays.
Table 1: | Chemical composition of P. graveolens methanolic extract |
Fig. 1: | DPPH free radical scavenging activity of methanolic extract of P. graveolens depending on concentrations compared with ascorbic acid |
Results, in Fig. 1, revealed that with increasing concentrations of extract, the higher the percentage of scavenged free radicals. The concentrations that were used ranged from 75-1000 μg mL1 and the extract showed significantly high antioxidant activity (87.7% at 1000 μg mL1).
The above result was compared with the free radical scavenging activity of ascorbic acid as a positive control, in which, according to the Fig. 1, the extract showed almost the same dose-dependent pattern as ascorbic acid free radical scavenging activity, especially at concentrations of 500 and 1000 μg mL1.
The was calculated and demonstrated that the inhibitory effects of methanol and ascorbic acid for DPPH were 484 and 292 μg mL1, respectively.
Table 2: | Count of viable cell after exposure to different concentrations of P. graveolens methanolic extract on MCF-7 cells |
Cytotoxic effects of P. graveolens extracts on MCF-7 cells using the MTT assay: The assay of 3-(dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) was used to determine the cytotoxic effects of P. graveolens extract on MCF-7 cells. This assay was performed to measure the cell viability and inhibition rate through applying different concentrations of P. graveolens extract to the tumor cell lines.
Data analysis carried out in μg mL1 and log values of μg mL1 was plotted on a Graphpad Prism 6 using log (Inhibitor) versus response curve. The most effective concentrations were chosen based on the most significant IC50 values. Cell viability at each time-point was determined by MTT colorimetric assays.
Results indicated that exposure of MCF-7 cells to methanol extract at concentrations from 25-400 μg mL1 for 24 h showed a reduction in cell viability in a dose-dependent manner, in which the cell viability decreased with increasing concentrations of methanolic extract. The lowest MCF-7 cell viability (38%) was recorded at 400 μg mL1. On the other hand, the extract significantly showed the most potent cytotoxic activity with an IC50 value of 288 μg mL1.
Multi-parameter cytotoxic activity of P. graveolens extract: A multi-parameter cytotoxic activity with the P. graveolens methanolic extract was implemented in HCS using MCF-7 cells. Five different measurements (cell count viability, nuclear intensity, cell membrane permeability, mitochondrial membrane potential and cytochrome C release) were detected in this assay and images of treated (extract and doxorubicin) and untreated MCF-7 cells were also captured.
Results showing in Fig. 2, demonstrate that the viable count of MCF-7 cells decreased with increasing concentrations of P. graveolens extract when compared with untreated cells. The reduction in cell count (percentage inhibition rate) was observed at rates of 10.20, 15.12, 29.5 and 53.92% for cells treated with 25, 50, 100 and 200 μg mL1 of P. graveolens methanolic extract, respectively (Table 2).
This result suggests highly that the methanolic extract is cytotoxic against MCF-7 cells as observed by the MTT assay, in which the reduction of the cell count was dose dependent and the most significant reduction appeared (p<0.0001) after applying a high dose (200 μg mL1) of extract.
Fig. 2: | Reduction in MCF-7 cell count after 24 h exposure to different concentrations of P. graveolens methanolic extract at 37°C and evaluated on the ArrayScan HCS reader, mean differences for significance were made between the untreated cells and the whole group |
Table 3: | Effect of different concentrations of P. graveolens methanolic extract on nuclear intensity, CMP, MMP and cytochrome C release |
NI: Nuclear intensity, CMP: Cytoplasmic membrane permeability, MMP: Mitochondrial membrane potential |
This result suggests highly that the methanolic extract is cytotoxic against MCF-7 cells as observed by the MTT assay, in which the reduction of the cell count was dose dependent and the most significant reduction appeared (p<0.0001) after applying a high dose (200 μg mL1) of extract.
Figure 3 shows the representative images acquired from the multi-parametric (nuclear intensity, cell membrane permeability, mitochondrial membrane potential and cytochrome C release) cytotoxic effects on a MCF-7 cell nucleus and mitochondria. The exposure of MCF-7 cells to P. graveolens extract at higher concentrations causes increased nuclear size, due to nuclear swelling and increased cell membrane permeability. The morphology of the nucleus (Hoechst blue) showed a nuclear condensation, which often appeared at high concentrations of P. graveolens extract (100 and 200 μg mL1). Both these effects were significantly different (p<0.1 and p<0.0001, respectively) from that of untreated cells (Fig. 4a) and such events were not induced at lower concentrations of P. graveolens.
On the other hand, Fig. 4b shows that the intensity of MCF-7 cell membrane permeability (green) gradually increased in a dose dependent pattern and that significant increase were observed after exposure to 100 and 200 μg mL1 of P. graveolens. Data analysis (Table 3) for the resulting fluorescent intensity of the extract and doxorubicin treated cells, compared with that of untreated cells, revealed that the nuclear intensity significantly increased approximately 1.3 fold after exposure to 200 μg mL1 of the extract, compared with 20 μM doxorubicin, a strong antitumor chemotherapy intercalating DNA molecule that causes massive DNA damage17, which showed a 2 folds increase in intensity.
However, the average fluoresce data for the cell membrane permeability showed a dose dependent pattern, starting from 1 fold at 25 μg mL1 and increasing to 2.3 folds at 200 μg mL1, with significant differences (ranging from p = 0.01 to p<0.0001) as compared with untreated MCF-7 cells.
Another two parameters, mitochondrial membrane potential and cytochrome C release were also measured. In comparison as shown in Fig. 5a, only higher concentration of P. graveolens extract (200 μg mL1) induced a significant (40.3%, p<0.0001) reduction in mitochondrial membrane potential, while the positive doxorubicin control cause a reduction up to 71.9%.
Fig. 3: | Multiparameter cytotoxicity (HCS) analysis of P. graveolens extract-treated MCF-7cell line after 24 h of incubation at 37°C. Cells were stained with Hoechst 33342 (Blue) (Ex 330 nm/Em 420 nm) dye which enables monitoring of cell loss, nuclear morphology changes and DNA content, permeability dye (Green) (Ex 491 nm/Em 509 nm) for membrane permeability monitoring, MMP dye (Red) (Ex 552 nm/Em 576 nm) for mitochondrial membrane potential changes and with goat anti-mouse secondary antibody conjugated with DyLightTM for cytochrome C releasing |
Fig. 4(a-b): | Effects of P. graveolens methanolic extract exposure on MCF-7 cell line for 24 h, (a) Neuclear intensity effect and (b) Cell membrane permeability effect. The effect was evaluated on the ArrayScan HCS reader, mean differences for significance were made between the untreated cells and the whole group |
The measurement of mitochondrial membrane potential depended on the average intensity of MMP dye that punctuate the mitochondria within the per-nuclear cytoplasmic region18 and the lower the fluorescent intensity, the higher the effect against the mitochondria. On the other hand, the release of cytochrome C was only significantly (p = 0.0005) induced after MCF-7 cell were exposed to 200 μg mL1 extract (Fig. 5b). The release of cytochrome C was detected by a 0.7 fold increase in the average fluorescent intensity of the treated MCF-7 cells, compared to untreated cells, whereas doxorubicin recorded a 1.5 fold increase in intensity (Table 3).
Detection of ROS: The ability of P. graveolens to affect the intracellular redox parameters related to oxidative stress was detected by measuring ROS generation, using MCF-7 tumor cells, for 24 h. The level of ROS was determined using Cellomics ROS Kit (ThermoScientific).
Fig. 5(a-b): | Effects of P. graveolens methanolic extract exposure on MCF-7 cell line for 24 h, (a) Mitochondrial membrane potential and (b) Cytochrome C release. The effect was evaluated on the ArrayScan HCS reader; mean differences for significance were made between the untreated cells and the whole group |
Figure 6 shows that only higher concentrations of P. graveolens extract exhibited significant increases in the ROS levels, specifically 0.53 fold ROS generation at 100 μg mL1 and 1.32 folds ROS generation at 200 μg mL1 as compared with untreated MCF-7 cells. Meanwhile, lower concentrations of P. graveolens extract showed no significant alteration in redox balance, also as compared with non-treated cells (Table 4).
DISCUSSION
The DPPH is characterized as a stable radical, owing to the delocalization of the spare electron, with a maximum absorption at approximately 517 nm and it has been frequently used to determine the antioxidant activity of different substances, including plant extracts19.
Fig. 6: | Effect of different concentrations of P. graveolens methanolic extract on ROS generation in MCF-7 cells |
Table 4: | Mean intensity of different P. graveolens methanolic extract concentrations on ROS induction in MCF-7 cells |
The antioxidant activity of the P. graveolens methanolic extract can be attributed, at least partially to the presence of essential oil compounds, including β -citronellol and geraniol and its ability to reduce free radicals by quenching reactive oxygen species and trapping radicals before they reach their cellular targets5. Many studies have exposed the radical-scavenging activity of extracts and essential oils of P. graveolens using the DPPH assay with values ranged from 63.70 mg mL1 (leaves) to 64.88 mg mL1 (stems) for essential oils20. In addition, Marangoni and de Moura21, mentioned that the use of essential oil extracted from Coriandrum sativum presented stronger synthetic antioxidant effects than butyl hydroxyl toluene on the delay of lipid oxidation.
Free radical scavenging activity is highly dependent on the type of solvent used in the extraction process, due to the differences in polarities and extraction abilities of the potentially antioxidant phytochemicals22. Since methanol is an amphiphilic compound, it's capable of extracting most of the various chemical groups from the plant material. Therefore, the methanol extract of P. graveolens had the highest activity among different extracts23. This observation is in agreement with a previous study of Chahmi et al.24, in which they compared the antioxidant power against DPPH of Inula viscosa extracts using different organic and alcoholic solvents. They also reported that ethanol was more effective organic solvent than ethyl acetate.
Free radicals play a key role in the development of a number of adverse health conditions, including cancer, cardiovascular disease and cataracts and have also been responsible in both initiation and acceleration of the aging process25. It is well known that free radicals cause oxidation, which can be controlled or prevented through a range of antioxidant substances26.
Natural antioxidants present in medical plants may be useful as a treatment for the prevention of oxidative damage during aging27. Many medicinal plants have great antioxidant potential, which can reduce the oxidative stress in cells and is therefore useful in the treatment of many human diseases, including cancer, cardiovascular diseases and inflammatory diseases28.
The P. graveolens is often used as a medicinal herb in different areas of the world due to its biological activities, which include bactericidal, antifungal and antiviral activities as well as antioxidant activities29. However, very little research has been reported on the antitumor activity of P. graveolens extracts. The cytotoxic effect observed with MCF-7 cells exposed to methanolic extract may be attributed to the presence of essential oils, which are considered to be the major constituent in P. graveolens that causes a wide variety of biological activity. Such indications are in agreement with Fayed8 which reported that the essential oils from the aerial parts of P. graveolens showed a potent cytotoxic effect in HL-60 and NB4 human leukemic cell lines with an LC50 value up to 86.5 μg mL1. In addition, significant inhibition (60-90%) of MIAPaCa2 pancreatic tumor cells was achieved with geraniol, one of the major essential oil constituents of P. graveolens30.
Some studies correlated the anti-inflammatory activity and cytotoxic activity (anti-tumor activity) of P. graveolens essential oils in such a way that the essential oils can provoke immunity in patients suffering from cancer. Zhuang et al.31 reported an approved trial where 66 breast cancer patients (stage I-IV) were treated with surgery followed chemotherapy or radiotherapy and were enrolled in administration of herb complex, which included essential oils from P. graveolens. Their results suggested that using herb complex had the capacity to delay the reduction in levels of leucocytes and neutrophils experienced by patients during cancer treatment.
Cell-based-high content screening is considered to be a more predictive assay when compared with conventional MTT cytotoxicity. It covers a broad range of effects and monitors multiple and independent toxicities in the same cell with a quantitative measurement of many parameters related to toxicity12,32. Therefore, this assay was adopted to monitor the different parametric effects of P. graveolens methanolic extract on MCF-7 cells. Depending on the results, the significant reduction of MCF-7 cells at higher concentrations of extract may be attributed to the induction of cellular apoptosis. The condensed and bright intensity of the Hoechst blue stain was attributed to nuclear condensation and the following observations are typical features of apoptotic cell morphology: Nuclear condensation, nuclear fragmentation, cell shrinkage and formation and aggregation of apoptotic bodies33,34. In addition, the use of membrane permeability dye and the increasing intensity of this dye, especially at the highest exposure concentration, supporting the fact that the extract can induce apoptosis in MCF-7 cells, since this dye can only stain the cells when the plasma membrane permeability increases due to the loss of plasma membrane integrity18,35.
This is little information available that is related to the cytotoxic effect of P. graveolens extract on tumor cells. However, since essential oils are the major constituents of P. graveolens, many studies and reviews indicate that essential oils extracted from different plants species show antitumor and cytotoxic activity through multiple pathways and mechanisms. These proposed pathways include: Apoptosis, cell cycle arrest, anti-metastatic and anti-angiogenic36,37. Many studies have investigated the cytotoxic and suppressing activity of plant natural products on tumor cells and revealed that these cells show an increase in expression of the p53 protein by triggering the up-regulation of the p53 gene and down-regulation of the Bcl-2 anti-apoptotic gene13,38.
One of the most distinctive features of cell death or when a cell undergoes apoptosis is the disrupting of active mitochondria39. The MMP dye was used to detect the functionality of active mitochondria; it has the ability to accumulate in mitochondria that maintain their inner membrane potential40. Compared with the doxorubicin exposure, results indicated that only 200 μg mL1 of P. graveolens methanolic extract triggered a significant reduction in mitochondrial brightness, which may be due to changes in the mitochondrial transmembrane potential caused by the triggering of apoptosis in MCF-7 cells. It has been suggested that these changes in the membrane potential are due to the opening of the mitochondrial permeability transition pores, allowing the transition of ions and small molecules, like calcium ions and consequently leading to the decoupling of the respiratory chain and release of cytochrome c into the cytosol41. Finally, the release of cytochrome c activates a series of caspases, specifically cysteine proteases, which are mainly responsible for the degradation and digestion of the cell from inside41,42.
The ROS are constantly generated and eliminated in a biological system and normal cells control the levels of ROS by balancing their generation and elimination using scavenging systems43. However, for cells under chemical or environmental stress, ROS are overproduced and this leads to modification of cell morphology, structure and cell apoptosis13.
Increased levels of ROS generation are associated with the control of multiple interacting molecules, including antioxidant enzymes. Cellular injury or exposure to chemicals will dramatically affect the intracellular balance between antioxidant enzymes and lead to overproduction of ROS44.
Some natural compounds as well as doxorubicin, can induce the generation of ROS and trigger cells to undergo apoptosis13. The excessive production of ROS after exposure to the higher concentrations of P. graveolens extract may contribute to the destruction of the mitochondrial membrane potential and eventually result in releasing of apoptotic cytochrome C. Furthermore, Gibellini et al.45 described how higher levels of ROS can destroy cellular DNA and plasma membrane, resulting in higher permeability of the plasma membrane and DNA fragmentation. Similar findings were observed throughout this study.
The P. graveolens is a well-known plant with uses in traditional medicine and pharmacy, in addition to its activity as an antioxidant46. However, little information is available regarding the ability or the cellular and molecular mechanism of P. graveolens in reducing ROS and scavenging oxidants, especially cellular redox that is not influenced by only one factor or molecule. The observed reduction in oxidative stress may be attributed to the important role of essential oils, including geraniol and β-citronellol as antioxidants. In addition, geraniol has been reported to exhibit significant antioxidant properties by stabilizing and protecting the cell membrane against oxidative stress47.
CONCLUSION
In conclusion this study report that the methanolic extract of P. graveolens exhibited a significant antioxidant activity and has profound cytotoxic activity against MCF-7 cell line. The extract induces ROS cell generation and in turn causes DNA damage, increasing in cytoplasmic membrane permeability and affecting the mitochondrial membrane potential and the releasing of cytochrome C release.
ACKNOWLEDGMENT
The authors are grateful to the College of Applied Biotechnology at Al-Naharin University for offering the space and utilities for accomplishing the project.